The IL-5 inhibitor is already available under the Fasenra brand name for maintenance use in severe eosinophilic asthma, but a ...
For the first time in five decades, researchers have identified a groundbreaking treatment for asthma attacks. The new ...
A new study testing the efficacy of antibody injections as a treatment for severe asthma has yielded promising results. But ...
Systemic corticosteroids (CS) should be considered as first-line treatment for acute asthma exacerbations, especially severe exacerbations. They may sometimes require a few hours or more to ...
Secondary prevention, exemplified by allergen-specific immunotherapy, has a place in the effort to avert acute attacks; however, its use is restricted within the allergic asthma subtype.
Benralizumab, the first new treatment for asthma attacks and chronic obstructive pulmonary disease (COPD) in 50 years, was initially approved by US and EU regulators in 2017. It was specifically ...
A groundbreaking new treatment for asthma and chronic obstructive pulmonary disease (COPD) is being hailed by doctors as a ...
During an attack, the airways become more swollen and blocked, making it harder to breathe. Asthma attacks can range from mild to severe, requiring immediate medical attention to relieve symptoms and ...
An injection given during some asthma and COPD attacks is more effective than the ... can reduce inflammation in the lungs but have severe side-effects such as diabetes and osteoporosis.
The first new treatment for asthma attacks in 50 years may be a “game ... It is currently used as a repeat treatment for severe asthma at a low dose, but a new clinical trial has found that ...
The first new treatment for asthma attacks in 50 years has been hailed ... life-threatening breathing difficulties in people with a severe form of the disease. The monoclonal antibody specifically ...
LONDON, Nov 27 (Reuters) - AstraZeneca's (AZN.L), opens new tab Fasenra, an injectable treatment for severe asthma, is more effective during attacks than the oral steroid that has been the ...